Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-10 08:22 am Purchase |
2021-12-31 | 13G | Johnson & Johnson JNJ |
The Vanguard Group | 234,782,632 8.920% |
6,836,528 (+3.00%) |
Filing History |
| 2022-02-07 1:32 pm Purchase |
2021-12-31 | 13G | CVRx, Inc. CVRX |
JOHNSON & JOHNSON JNJ |
4,109,573 19.600% |
4,109,573 (New Position) |
Filing History |
| 2022-02-01 2:42 pm Unchanged |
2021-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ |
JOHNSON & JOHNSON JNJ |
1,607,044 3.300% |
0 (Unchanged) |
Filing History |
| 2022-01-31 5:49 pm Purchase |
2021-12-31 | 13G | Johnson & Johnson JNJ |
BLACKROCK INC BLK |
200,021,352 7.600% |
11,510,810 (+6.11%) |
Filing History |
| 2021-02-12 4:27 pm Sale |
2020-12-31 | 13G | Johnson & Johnson JNJ |
STATE STREET CORP STT |
144,029,634 5.470% |
-7,837,599 (-5.16%) |
Filing History |
| 2021-02-10 11:10 am Sale |
2020-12-31 | 13G | Johnson & Johnson JNJ |
The Vanguard Group | 227,946,104 8.660% |
-351,671 (-0.15%) |
Filing History |
| 2021-02-01 5:41 pm Unchanged |
2020-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
JOHNSON & JOHNSON JNJ |
2,449,183 5.700% |
0 (Unchanged) |
Filing History |
| 2021-01-29 5:22 pm Sale |
2020-12-31 | 13G | Johnson & Johnson JNJ |
BLACKROCK INC BLK |
188,510,542 7.200% |
-4,560,846 (-2.36%) |
Filing History |
| 2020-07-02 6:21 pm Purchase |
2020-06-30 | 13G | Fusion Pharmaceuticals Inc. FUSN |
JOHNSON & JOHNSON JNJ |
3,759,634 9.000% |
3,759,634 (New Position) |
Filing History |